+ All Categories
Home > Documents > Medical requirements for FFAG as proton beam sources

Medical requirements for FFAG as proton beam sources

Date post: 04-Jan-2016
Category:
Upload: joy
View: 46 times
Download: 4 times
Share this document with a friend
Description:
FFAG 2007, April 12-17, 2007 Grenoble. Medical requirements for FFAG as proton beam sources. Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE. Plan. Why to use protons in radiotherapy ? What kind of tumors are presently treated by protons ? - PowerPoint PPT Presentation
Popular Tags:
32
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007 Grenoble
Transcript
Page 1: Medical requirements for FFAG as proton beam sources

Medical requirements for FFAG as proton beam sources

Jacques BALOSSO, MD, PhD

Radiation oncologiste

UJF / INSERM / ETOILE

FFAG 2007, April 12-17, 2007 Grenoble

Page 2: Medical requirements for FFAG as proton beam sources

Plan

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 3: Medical requirements for FFAG as proton beam sources

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 4: Medical requirements for FFAG as proton beam sources

The protons Bragg peak

The 200 MeV Bragg peak of the CPO (Orsay, France)

Page 5: Medical requirements for FFAG as proton beam sources

The protons Spread Out Bragg Peak (SOBP)

The inside structure of the proton SOBP

Page 6: Medical requirements for FFAG as proton beam sources

Comparison of the « efficient » dose according to the depth for photons, a proton SOPB and a carbon ion SOBP. (GSI, Darmstadt, Germany)

Page 7: Medical requirements for FFAG as proton beam sources

PSI Villigen

Page 8: Medical requirements for FFAG as proton beam sources

PSI Villigen

Page 9: Medical requirements for FFAG as proton beam sources

PSI Villigen

Page 10: Medical requirements for FFAG as proton beam sources

PSI Villigen

Page 11: Medical requirements for FFAG as proton beam sources

Comparison of the « efficient » dose according to the depth for photons, a proton SOPB and a carbon ion SOBP. (GSI, Darmstadt, Germany)

Page 12: Medical requirements for FFAG as proton beam sources

X-Rays Protons Carbone

Neutrons

RBE 1

RBE >> 1

Page 13: Medical requirements for FFAG as proton beam sources

Protons and Carbon ions are not offering the same advantages

• Protons are representing a crude and important ballistic improvement for any type of radiotherapy…

providing they are affordable !

• Carbones are an innovative kind of radiations with particular radiobiological properties suitable for certain indications only.

Page 14: Medical requirements for FFAG as proton beam sources

Indication for Indication for a fractionated a fractionated radiotherapy radiotherapy of RBE of RBE 1 1

Indication for Indication for particle particle therapy having therapy having an RBE >> 1an RBE >> 1S

urv

ival

Page 15: Medical requirements for FFAG as proton beam sources

Consequently …

• Protons indications are not limited

• Protons can, with the time, replace X-Rays

• Carbon ions should have a definitive and limited number of indications

• These indications are a number of therapeutic spots present in different groups of tumors.

Page 16: Medical requirements for FFAG as proton beam sources

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 17: Medical requirements for FFAG as proton beam sources

Indications for protontherapy in Loma Linda (1)

• Brain and spinal cord– Isolated brain metastases– Pituitary adenomas– Arteriovenous malformations (AVMs)

• Base of skull– Meningiomas– Acoustic neuromas– Chordomas and chondrosarcomas

• Eye– Uveal melanomas

In red: indications treated in France

Page 18: Medical requirements for FFAG as proton beam sources

Indications for protontherapy in Loma Linda (2)

Head and neck– Nasopharynx– Oropharynx (locally advanced)

• Chest and abdomen– Medically inoperable non-small-cell lung cancer– Chordomas and chondrosarcomas

• Pelvis– Prostate– Chordomas and chondrosarcomas

• Tumors in children– Brain– Orbital and ocular tumors– Sarcomas of the base of skull and spine

Page 19: Medical requirements for FFAG as proton beam sources

Uvea melanoma treated by protons

Page 20: Medical requirements for FFAG as proton beam sources

Chondrosarcoma of the skull base

Page 21: Medical requirements for FFAG as proton beam sources

Chordoma

Page 22: Medical requirements for FFAG as proton beam sources

Meningioma

Page 23: Medical requirements for FFAG as proton beam sources

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 24: Medical requirements for FFAG as proton beam sources

Indications for protontherapy in Loma Linda (1)

• Brain and spinal cord– Isolated brain metastases +++– Pituitary adenomas– Arteriovenous malformations (AVMs)

• Base of skull– Meningiomas– Acoustic neuromas– Chordomas and chondrosarcomas

• Eye– Uveal melanomas

In red: indications treated in France

Page 25: Medical requirements for FFAG as proton beam sources

Indications for protontherapy in Loma Linda (2)

Head and neck– Nasopharynx +++– Oropharynx (locally advanced)

• Chest and abdomen– Medically inoperable non-small-cell lung cancer +++– Chordomas and chondrosarcomas

• Pelvis– Prostate +++– Chordomas and chondrosarcomas

• Tumors in children– Brain– Orbital and ocular tumors– Sarcomas of the base of skull and spine

Page 26: Medical requirements for FFAG as proton beam sources

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 27: Medical requirements for FFAG as proton beam sources

Technical requirements

• Depth: 2 to 30 cm in water• Size: at least 10 x 10 cm up to 20 x 20• Dose rate: at least one Gy / min / liter• Precision of size & position: 1 mm• Precision of the dose: +/- 2 to 3%• Operability: > 97%• Session time: < 30 min• Beam control: active +++ (rapid change of

energy ??) better than passive

Page 28: Medical requirements for FFAG as proton beam sources

Exemple of a single proton beam

Page 29: Medical requirements for FFAG as proton beam sources

Exemple of the set-up with a gantry

Page 30: Medical requirements for FFAG as proton beam sources

• Why to use protons in radiotherapy ?

• What kind of tumors are presently treated by protons ?

• What kind of tumors would be treated by widely available proton beams?

• Requirement for a medical proton source

• Prospective for a radiotherapy of the future

Page 31: Medical requirements for FFAG as proton beam sources

Toward the future of radiotherapy

• 100% hadrontherapy:– with 95% proton– and 5% light-ions (carbon…)

• High precision and small volume of early diagnozed tumors

• Few sessions of >> « 2 Gy »• Fast shot RT to reduce immobilization and to

favor precision of moving target treatment (lung, lever, prostate…)

• About 5000 treatments / 106 inhabitants per year in 20 years

Page 32: Medical requirements for FFAG as proton beam sources

Open questions

• What type of machine for the generalized availability of protons ?

• What are the radiobiological characteristic of very high dose rates ?

• What could be the organization and the economical conditions of very short but highly sophisticated treatments ?

• Could FFAG be an answer?


Recommended